Transe Vision Care

Bengaluru, India
Ophthalmic lens manufacturing and marketing in India.

About Transe Vision Care

Transe Vision Care is a Healthcare company based in Bengaluru (India). Ophthalmic lens manufacturing and marketing in India. It operates in the Healthcare and Industrial Goods & Manufacturing sectors. The company has 97 employees. Its Indian entity Transe Vision Care Private Limited reported revenue of β‚Ή26.21 Cr. Transe Vision Care offers products and services including Ophthalmic Lenses and Zylus. Its focus areas include Medical Devices, Ophthalmic Products, Lens Manufacturing and Manufacturing.

Company details

Transe Vision Care is identified as one of the fastest-growing entities in lens manufacturing, with operations established as a Make in India initiative. It has been active in the optical business for over a decade, with presence developed in Southern and Eastern parts of India and expansion efforts directed towards a pan-India scope. Various products, including Zylus, Hamara, TG, and Indys, are produced, alongside services such as training and warranties. The company is supported by multiple manufacturing units and a focus on quality standards.

Key Metrics
  • Annual Revenue
    ₹26.21 Cr

    FY 2025 · +30% YoY

  • Net Loss
    -₹6.68 Cr

    FY 2025 · -25% margin

  • EBITDA
    ₹1.38 Cr

    FY 2025 · 5% margin

  • Employee Count
    97

Products & Services of Transe Vision Care

Transe Vision Care offers a comprehensive portfolio of products and services, including Ophthalmic Lenses and Zylus.

Ophthalmic Lenses
Medical Devices

Ophthalmic lenses are manufactured and marketed for vision care purposes

Zylus
Lens Products

Zylus is offered as a specific type of lens within the product line

Board of directors of Transe Vision Care Private Limited (Transe Vision Care)

Transe Vision Care Private Limited is the primary company behind Transe Vision Care. The board of Transe Vision Care Private Limited currently have 4 directors; the longest-serving is Ramamurthy Bhuvaneswari, appointed in 2012. 7 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Ramamurthy Bhuvaneswari
DIN 05183287
Director24 Feb 201214 yrs 8 moTranse Vision Care Private Limited
Sundaresan Rajagopalan
DIN 02326171
Additional Director25 Jun 20188 yrs 4 moTranse Vision Care Private Limited
Kapil Jhaver
DIN 00341595
Director25 Dec 20196 yrs 10 moTranse Vision Care Private Limited
Rangarajan Vijayaragavan
DIN 09286859
Director28 Apr 20224 yrs 6 moTranse Vision Care Private Limited

Financials of Transe Vision Care

Figures of Transe Vision Care Private Limited, the primary company behind Transe Vision Care, for FY 2025. Revenue was ₹26.21 Cr (+30% year on year). Net loss was -₹6.68 Cr (-25% margin). EBITDA was ₹1.38 Cr (5% margin). Revenue has grown at a compounded annual rate of +39% over three years and +30% over five years.

  • ₹26.21 CrRevenue · FY 2025 · +30% YoY
  • -₹6.68 CrNet loss · -25% margin
  • ₹1.38 CrEBITDA · 5% margin
  • ₹5.88 CrPaid-up capital
  • 97Employees (provident fund records)
  • +39%Revenue CAGR, 3 years
  • +30%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Transe Vision Care Private Limited are on its company page.

Premium access

Detailed financial statements for Transe Vision Care

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Top companies in Ophthalmology

2 companies that operate in the same segment as Transe Vision Care (Ophthalmology) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
AI-powered portable solutions for ophthalmic screening and diagnosis are developed.
2009Bengaluru, Karnataka, IndiaUSD 25.01 MUSD 4.85 M135
Manufacturer of portable digital eye imaging devices and cloud-based healthcare platforms
2010Bengaluru, Karnataka, IndiaUSD 18.12 MUSD 4.78 M145
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Transe Vision Care

Transe Vision Care is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

Transe Vision Care has 97 employees.

The primary company behind Transe Vision Care, Transe Vision Care Private Limited, reported revenue of β‚Ή26.21 Cr for FY 2025, up 30% year on year.

Transe Vision Care is identified as one of the fastest-growing entities in lens manufacturing, with operations established as a Make in India initiative. It has been active in the optical business for over a decade, with presence developed in Southern and Eastern parts of India and expansion efforts directed towards a pan-India scope. Various products, including Zylus, Hamara, TG, and Indys, are produced, alongside services such as training and warranties. The company is supported by multiple manufacturing units and a focus on quality standards.

Transe Vision Care offers Ophthalmic Lenses and Zylus.

Transe Vision Care operates through Transe Vision Care Private Limited.

The legal entities of Transe Vision Care currently have 4 directors, including Rangarajan Vijayaragavan, Sundaresan Rajagopalan, Kapil Jhaver and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available